Magnesium therapy for periodic leg movements-related insomnia and restless legs syndrome: An open pilot study

Sleep

Volumn 21, Issue 5, 1998, Pages 501-505

  Hornyak, Magdolna ^a   Voderholzer, Ulrich ^a   Hohagen, Fritz ^a   Berger, Mathias ^a   Riemann, Dieter ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Magnesium; Periodic leg movements during sleep; Polysomnography; Restless legs syndrome; Therapy

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; MAGNESIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERANCE; DRUG USE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME;

EID: 0031826875     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/21.5.501     Document Type: Article

References (21)

1. Walters AS. Towards a better definition of the restless legs syndrome. Mov Disord 1995;10:634-42.
2. Guilleminault C, Mondini S, Montplaisir J, Mancuso J, Cobasco D, Dement WC. Periodic leg movement, L-dopa, 5-hydroxytryptophan, and L-Tryptophan. Sleep 1987;10:393-7.
3. Brodeur C, Montplaisir J, Godbout R, Marinier R. Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 1988;38:1845-8.
4. Trenkwalder C, Stiasny K, Pollmächer Th, Wetter Th, Schwarz J, Kohnen R, Kazenwadel J, Krüger HP, Ramm S, Künzel M, Oertel WH. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep 1995;18:681-8.
5. Guilleminault C, Cetel M, Philip P. Dopaminergic treatment of resless legs and rebound phenomenon. Neurology 1993;43:445.
6. Allen RP, Earley CJ. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 1996;19:205-13.
7. Spätling L, Spätling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstetr Gynecol 1988;95:120-5.
8. Söllner B. Hochdosierte orale Magnesiumtherapie in der Gynäkologie. Perfusion 1994;9:327-9.
9. Coleman RM. Periodic movements in sleep (nocturnal myoclonus) and restless legs syn-drome. In: Guilleminault C. ed. Sleeping and waking disorders. Addison-Wesley, Menlo Park, 1982:265-95.
10. Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 1988;28:193-213.
11. Görtelmeyer R. On the development of a standardized Sleep Inventory for the Asssessment of Sleep. In: Kubicki S, Herrmann WM eds. Methods of sleep research. Gustav Fischer Verlag, 1985:93-8.
12. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service 1968.
13. Walters AS, Hening WA, Kavey N, Chokroverty S, Gidro-Frank S. A double-blind cross-over trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 1988;24:455-8.
14. Walters AS, Wagner ML, Hening WA, Grasing K, Mills R, Chokroverty S, Kavey N. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993;16:327-32.
15. Mosko SS, Dickel MJ, Ashurst J. Night-to night variability in sleep apnea and sleep-related periodic leg movements in the elderly. Sleep 1988;11:340-8.
16. Bliwise DL, Carskadon MA, Dement WC. Nightly variation of periodic leg movements in sleep in middle aged and elderly individuals. Arch Gerontol Geriatr 1988;7:273-9.
17. Levine BS, Coburn JW. Magnesium the mimic antagonist of calcium. N Engl J Med 1984;310:1253-4.
18. El-Beheiry H, Puil E. Effects of hypomagnesia on transmitter actions in neocortical slices. Br J Pharmacol 1990;101:1006-10.
19. Decollogne S, Tomas A, Lecerf C, Adamowicz E, Seman M. NMDA receptor complex blockade by oral administration of magnesium: comparison with MK-801. Pharmacol Biochem Behavior 1997;58:261-8.
20. Classen HG, Speich M, Schimatschek HF et al. Functional role of magnesium in vivo. In: Golf S, Dralle D, Vecchiet L, eds. Magnesium 1993. London: John Libbey & Co. 1993:13-30.
21. Stendig-Lindberg G, Tepper R, Leichter I. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res 1993;6:155-163.